Skip to main content
Advertisement

< Back to Article

Multi-targeting of K-Ras domains and mutations by peptide and small molecule inhibitors

Fig 3

Validation of molecular docking method.

(A) Structural alignment of the K-RasG12D-peptide complex determined by X-ray crystallography (ID: 5XCO) and the docking model. Close-up view of the binding interface between K-RasG12D and inhibitory peptide in the (B) crystallography and (C) docking studies. The residues of K-RasG12D forming H-bond interactions with the peptide are shown in yellow.

Fig 3

doi: https://doi.org/10.1371/journal.pcbi.1009962.g003